CYC cyclopharm limited

Ann: Cyclopharm Receives USFDA Approval for Technegas, page-14

  1. 1,518 Posts.
    lightbulb Created with Sketch. 287
    Is it just me, or is the market that CYC is targeting super small?

    "Cyclopharm is initially targeting the 600,000 nuclear medicine imaging procedures for PE, a marketwhich it estimates to be approximately US$90 million per annum. Based on Cyclopharm’s experiencein the Canadian market and globally, the company reiterates expectations it can achieve a 50% shareof this market over the next 2 to 3 years, rising to in excess of an 80% share over a 3 to 5-year period."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $105.5M
Open High Low Value Volume
92.5¢ 97.5¢ 92.0¢ $80.23K 85.21K

Buyers (Bids)

No. Vol. Price($)
1 1076 93.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 3000 1
View Market Depth
Last trade - 15.58pm 25/06/2025 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.